PDF(Pubmed)
Abstract：
Irritable bowel syndrome is a typical gastrointestinal disease that causes bloating, flatulence, abdominal pain, diarrhoea, constipation, or alteration of the last two in adults and children. A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) is one of the potential treatment strategies to reduce abdominal symptoms and increase the quality of life. The present narrative review aims to present a general overview of current studies that have evaluated the efficacy of a low-FODMAP diet against other diets in gastrointestinal symptoms, nutrient intake in adults and children, and lifestyle quality. The research was performed using seven searchable databases, which included the Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews (CDSR), Excerpta Medica Database (EMBASE), Medline, PubMed, Scopus, and Web of Science, up to March 2023. In conclusion, there is significant evidence that the follow-up of a low-FODMAP diet might be a feasible first-line therapeutic strategy to reduce stomach discomfort, pain, bloating, and quality of life for patients with irritable bowel syndrome.
摘要：
肠易激综合征是一种典型的胃肠道疾病，会引起腹胀，胀气,腹痛,腹泻,便秘,或改变成人和儿童的最后两个。低可发酵寡糖的饮食，二糖，单糖，和多元醇（FODMAP）是减少腹部症状和提高生活质量的潜在治疗策略之一。本叙述性综述旨在对目前的研究进行总体概述，这些研究评估了低FODMAP饮食对其他胃肠道症状饮食的疗效。成人和儿童的营养摄入量，和生活质量。这项研究是使用七个可搜索的数据库进行的，其中包括Cochrane中央控制试验登记册（CENTRAL），Cochrane系统评价数据库(CDSR)，摘录医学数据库（EMBASE），Medline,PubMed,Scopus,和WebofScience,到2023年3月。总之,有重要证据表明，低FODMAP饮食的随访可能是减少胃部不适的可行的一线治疗策略。疼痛,腹胀,以及肠易激综合征患者的生活质量。
